News from all angles
(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase I…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network